TrialPloS one2020

Improved residual fat malabsorption and growth in children with cystic fibrosis treated with a novel oral structured lipid supplement: A randomized controlled trial.

Virginia A Stallings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.